Institutional members access full text with Ovid®

Share this article on:

A Novel Enteral Nutrition Protocol for the Treatment of Pediatric Crohn’s Disease

Gupta, Kernika BA*; Noble, Angela MD; Kachelries, Kelly E. RD*; Albenberg, Lindsey DO*; Kelsen, Judith R. MD*; Grossman, Andrew B. MD*; Baldassano, Robert N. MD*

doi: 10.1097/MIB.0b013e318281321b
Original Clinical Article

Background: Enteral nutritional therapy (EN) is an effective modality for inducing and maintaining remission in pediatric patients with Crohn’s disease (CD). The standard protocol for EN provides patients with 100% of their caloric needs for induction of remission. The aim of this study was to determine the efficacy of delivering 80% to 90% of patient’s caloric needs through EN, to induce remission in pediatric patients with CD. This approach allows patients to consume remaining calories from a normal diet.

Methods: A retrospective review of charts from 1998 to 2010 was conducted at The Children’s Hospital of Philadelphia. Remission (Pediatric Crohn’s Disease Activity Index <10) and response (decrease in Pediatric Crohn’s Disease Activity Index score of ≥12.5 points) were calculated before and after treatment with EN. Weight z scores and laboratory parameters were evaluated in all participants.

Results: Forty-three charts were evaluated. Mean age of participants was 12.8 years (5.1–17.4), 67% were male and 33% female patients. Remission and response were evaluated in a group of 23 participants, with no missing data. There were reductions in erythrocyte sedimentation rate (P < 0.0001) and C-reactive protein (P < 0.02), and increases in albumin (P < 0.03). Mean Pediatric Crohn’s Disease Activity Index score at baseline was 26.9 and was reduced to a score of 10.2 at follow-up (P < 0.0001). Induction of remission was achieved in 65% and response in 87% at a mean follow-up of 2 months (1–4 months).

Conclusions: This novel EN protocol seems to be effective for the induction of remission in pediatric patients with CD and contributes to increasing weight and improving laboratory markers. This protocol may result in improved EN acceptance and compliance and will be evaluated prospectively.

Article first published online 4 April 2013

*Division of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; and

Pediatric Gastroenterology, Kingston General Hospital, Kingston, Ontario, Canada.

Reprints: Kernika Gupta, BA, Children’s Hospital of Philadelphia, Division of Gastroenterology, Hepatology and Nutrition, 3401 Civic Center Boulevard, Philadelphia, PA 19104 (e-mail:

The authors have no conflicts of interest to disclose.

Received August 31, 2012

Accepted September 05, 2012

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website